chrisvoncsefalvay/vaers-outcomes huggingface dataset:
NECK LOCKED UP; ARM DEAD; PAIN ABOVE ELBOW; HIGH FEVER; SHEETS COMPLETELY SOAKED; This spontaneous report received from a consumer concerned a 42 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included the patient had no known allergies and no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced sheets completely soaked. On APR-2021, the subject experienced high fever. Treatment medications included: diazepam, and lidocaine. On 15-APR-2021, the subject experienced neck locked up. On 15-APR-2021, the subject experienced arm dead. On 15-APR-2021, the subject experienced pain above elbow. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from high fever on APR-2021, was recovering from neck locked up, had not recovered from arm dead, and pain above elbow, and the outcome of sheets completely soaked was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
02/02/22 presents to ED for "Dyspnea". PMHx of "hypertension, hyperlipidemia, diabetes mellitus, and coronary artery disease"
Very high fever- 104, immobilizing aches and pains, severe headache, chills.. Injection site and surrounding 6 Inches swollen, red and inflammed.
WEAKNESS; NIGHTMARE; UNABLE TO SLEEP; CHILLS; HEADACHE; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergic to antibiotics, alcohol, non smoker, and penicillin allergy, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug usage.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 12:00 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, treatment medications included: paracetamol. On 07-APR-2021, the subject experienced nightmare. On 07-APR-2021, the subject experienced unable to sleep. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced headache. Laboratory data included: Pain scale (NR: not provided) 8/10. On 08-APR-2021, the subject experienced weakness. Laboratory data included: Pain scale (NR: not provided) 2/10. Treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headache, and chills, had not recovered from weakness, and the outcome of nightmare and unable to sleep was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious
she developed a lump on her elbow; runny nose; cold like symptoms; rash on forearm; forearm, burning itching sensation like fire ants/burning itching sensation on head/Behind ears and neck also felt this way; This is a spontaneous report from a non-contactable consumer, the patient. A 58 age (unit not reported) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on 05Mar2021 as a single dose for covid-19 immunization. Medical history included psoriasis (She has a past medical history of psoriasis and was on Otezla for 4 years but discontinued using it in September. Before receiving the vaccine she had a small patch of psoriasis on her breast), pruritus (Burning itching sensation on head. Has a history of this on other parts of her body but not on her head). The patient's concomitant medications were not reported. The patient previously took otezla for psoriasis. On 07Mar2021, after receiving the vaccine she developed a lump on her elbow, a runny nose and cold like symptoms into Sunday. Sunday around 11 she developed a rash on forearm, burning itching sensation like fire ants, put ice on it and feeling went away. Last night around 9 pm, she started having burning itching sensation on head. Has a history of this on other parts of her body but not on her head. Behind ears and neck also felt this way but she did not put ice on them. Can the vaccine trigger psoriasis and will it ever go away. Outcome of the event pruritus was recovered and for rest other events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
FluMist given 28Jan05, Sat 29Jan Developed B Deep nostril pain, nasal discharge to include blood. Blisters (vesicles) appeared to lateral aspects nose (external) on Sun 29Jan05. Markedly tender. Likely nasal herpes outbreak.
tingling or numbness on her arm, going down her arm and a little on her feet; tingling or numbness on her arm, going down her arm and a little on her feet; This is a spontaneous report from a contactable consumer. This consumer (husband) reported for a female patient (wife) that; A female patient of an unspecified age (Age:44, Unit: Unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration, administrated in the "arm" on 08Mar2021 as single dose for COVID-19 immunization. The patient relevant medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced slight tingling or numbness on her arm, going down her arm and a little on her feet. It was reported that, calling on behalf of his wife. Received first dose (08Mar2021) Monday. Experienced numbness, tingling on side of administration. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Case number PHEH2015US004133 is an initial spontaneous report received from medical assistant on 27 Feb 2015: This case refers to a 15 months old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: U5036CA, U501BAA, U5018AA, UI173AB, UI173AB, UI2017AB, UI2O7AB, 14511F) at a dose of 0.5 ml intramuscularly on 26 Feb 2015, which reached 31 degree Fahrenheit for two hours. No adverse event was reported following this administration error.
Lingering Fatigue, muscle aches, headache/fever, swollen lymph nodes, chest cold and cough for weeks
Shot given 10/23 at 01:45 pm. Pt experienced a lump, pain, stiffness, and swelling on 05:00 pm on 10/23.  On sat 10/24 pt noticed redness as well.
Swelling, reddening, heat, pain, difficulty moving arm at injection site. Pt stated symptoms started 7 pm same day and symptoms were gone by 11/24/13.
Cellulitis, arm was warm and inflamed.  Pt reported that she got an antibiotic and Benadryl from urgent care.
it had only been 21 days and not 28 days since the first dose, Patient ended up receiving the second dose on 26Feb2022; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (it had only been 21 days and not 28 days since the first dose, Patient ended up receiving the second dose on 26Feb2022) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Feb-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2022,  after starting mRNA-1273 (Spikevax), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (it had only been 21 days and not 28 days since the first dose, Patient ended up receiving the second dose on 26Feb2022). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (it had only been 21 days and not 28 days since the first dose, Patient ended up receiving the second dose on 26Feb2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Patient has received first dose on 05Feb2022 and was due 28 days later on 05Mar2022 but the patient confused the time frame for 21 days after and not 28 days. Patient ended up receiving the second dose on 26Feb2022. No concomitant medication were provided No treatment details were provided   Most recent FOLLOW-UP information incorporated above includes: On 10-Mar-2022: No new information received
Three weeks after receiving the second dose of the Pfizer/BioNTech COVID19 vaccine, I started to experience a marked increase in neuropathy symptoms including burning, parasthesias, fasciculation and pins and needles.  I have a pre-existing peripheral neuropathy, but it had been stable prior to vaccination for a number of years.  The flare up in symptoms was the worst of the 27 years that I have had the neuropathy and continues unabated to this day (roughly four months later).   I do not know if this increase in symptoms is permanent or not at this stage.
First dose recieved 3/25/21, report from passenger in the vehicle with the patient. They were traveling back from San Diego on April 16th, when the passenger noted that he went into the passing lane without another car in front of them. He then proceed to enter the median and began running over bushes. Passenger attempted to get the patient to stop, but was unresponsive, eyes were open but glassed over. Once the car was stopped, he was confused and did not understand why the car was in the median. However,  they proceed along the way. Patient was very confused about specific routes and stops that he has travelled many times down the road, they stopped in in 2 other cities. It was not until they arrived to the 2nd city that the patient returned to normal. He has no recollection of these events.  Patient reports recurrence of these confusional episodes after his second dose as well.
3 migraine headaches w/in 1st 5 days of shot (I don't have migraines); then repeated projectile vomiting on 6th day (w/in 20-30 min. period), "malaise" starting evening of the shot. Sore throat, fever, sinus infection symptoms/laryngitis/aphonia for 2 days with dysphonia for resulting 4 weeks. Total length illness 5 1/2 weeks. Saw urgent care at the hospital at 5 week I was given a steroid type shot.
From telephone correspondence rec'd on 10/4/02, it was reported that a child rec'd a dose of Tripedia on 10/3/02. Later that evening the pt had a 101F temperature and symptoms of a cold were present. The pt's mother brought the child to the Dr's office on 10/4/02. The pt's temperature was then 103.5F and the Dr referred the pt to the hospital for assessment. It was not reported whether the child was admitted to the hospital or whether the pt recovered.
Patient fully vaccinated (Moderna) but not boosted, admitted to the hospital on 1/18/2022 with COVID-19 and associated hypoxia. Patient was discharged on 1/17/2022.
This is the third of 3 injections. It felt immediately different and too high on the arm. Since the injection I have pain in my left shoulder with nearly any activity. Lifting my hand above my head hurts. I had not prior shoulder injury or problems.
Case number PHEH2013US025954 is an initial spontaneous report received from a nurse on 16 DEC 2013. This report refers to a 13-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with FLUCELVAX 2013/2014 (batch number: not reported) intramuscularly on 16 DEC 2013. No adverse events were reported following the maladministration.  Following an internal review on 18 AUG 2014, a significant correction was done for the information received on 16 DEC 2013: The BPI labeling of the event "inappropriate age at vaccine administration" changed from listed to unlisted and added second indication as "drug used in unapproved population".
child was not upset with the vaccine, 5 min after vaccine child walked out the clinic door and fainted and threw up, brought back into the clinic where she fell asleep, able to wake her for a very short amount of time for apple juice then fell back asleep for an hour in the clinic. mom carried her out asleep and brought her home where she slept another 1.5 hours then woke up and has been fine since.  no noted seizure like activity, was pale, but otherwise nl HR and resp
This spontaneous report as received from a healthcare worker (Certified Medical Assistant C.M.A.) refers to an unspecified number patients of unknown age and gender. Pertinent medical history and drug reactions or allergies were not specified. On an unknown date, the patients were vaccinated with doses of VARIVAX (Merck), 0.5 ml, subcutaneously, that were improperly stored. The VARIVAX (Merck) was exposed to a highest temperature of 26 Fahrenheit (F) for a total of 24 hours over three different excursions. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Physician is reporting that a patient was administered an expired ROTATEQ (11/11/2020) on 12/2/2020.; This spontaneous report was received from a physician, referring to a 8-weeks-old patient of unknown gender. The patient's pertinent medical history, current conditions, previous drug reactions or allergies and concomitant medications were not provided.   On 02-DEC-2020, the patient received an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), administered by oral route, as prophylaxis (formulation, strength and vaccination scheme were not reported, lot number 1660951, which has been verified to be valid, expiration date reported and validated as 11-NOV-2020) (expired product administered).
A report was received from a healthcare professional in the USA, via a company representative on 10/26/06, concerning a 55 year old male vaccinee. The vaccinee has a significant cardiac history. No details were provided regarding the vaccinee's concomitant medications. On 10/22/06, the vaccinee was administered Fluvirin, IM. On the same day, 10/20/06, the vaccinee experienced sweating and stomach pains. He called an ambulance and was admitted to the Emergency room with Myocardial Infarction. The vaccinee is still hospitalized. The nurse does not believe the vaccinee continues to have symptoms. The nurse does not consider the symptoms to be related to the vaccine due to the vaccinee's cardiac medical history. Follow up information will be sought.
Turn red (2 inches), very itchy, irritable. Took Benadryl 25 mg twice daily,  Voltaren gel., plus my daily zrytec & Montelukast.
This spontaneous report was received from a physician via a company representative referring to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions or concomitant medications was provided. On 16-JUN-2017, 2 weeks less than the 6 months minimum, the patient was vaccinated with the second dose of VAQTA, for prophylaxis, (dose, route, lot number and expiration date were not provided). No adverse effects were reported and no product quality complaint (PQC) was involved. Additional information has been requested.
Fever and some joint aches.  Took ibuprofen.  Started feeling better after 5 pills.
12/16: 1200 - dizziness 1700 - headache, fatigue 2000 - 101.9 fever, body aches, fatigue, dizziness, nausea 12/17: 0600 - dizziness, nausea 0800 - nausea, diarrhea - lasted throughout whole day
On 11/12/2021 all over hives outbreak began. Head, torso front and back, arms, legs, hands, feet. I contacted emergency care via telehealth and took 21 day prednisone course. After that began 4 x daily antihistimine beginning with Xyzal and now taking Allegra with varying degrees of efficacy. It's now, March 11 and it's the same if not worse all over body hives.
This spontaneous report as received from a register nurse, concerning a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 12-NOV-2013, the patient was vaccinated with a dose of GARDASIL (dose, lot number, expiration date, strength and route were not reported). Co-suspect and concomitant therapies were not reported. The register nurse reported one patient received improperly stored GARDASIL on 12-NOV-2013. The register nurse did not reported if this was the patient's first dose or if the patient received previous doses of GARDASIL. No adverse symptoms reported. Additional information has been requested.
Roughly 30 hours post vaccination, I began to feel pressure in my underarm on the same side I received the shot. My lymph node continued to swell over night and become more tender. This is still persisting 24 hours later as I report this. Additionally,  I've started to feel worn down and getting chills but not registering a fever.
Ankles are swollen; Can't walk properly; Pain in left ankle; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Ankles are swollen), GAIT DISTURBANCE (Can't walk properly) and ARTHRALGIA (Pain in left ankle) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21N and 044A21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, CHLORTHALIDONE and SIMVASTATINE for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (Ankles are swollen), GAIT DISTURBANCE (Can't walk properly) and ARTHRALGIA (Pain in left ankle). At the time of the report, JOINT SWELLING (Ankles are swollen), GAIT DISTURBANCE (Can't walk properly) and ARTHRALGIA (Pain in left ankle) outcome was unknown.            This case was linked to MOD-2021-078036 (Patient Link).
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Mar2021 as dose 1, single (Lot number: EN61996130121), in left arm, on 26Mar2021 as dose 2, single (Lot number: EP75346130121), in left arm, on 21Oct2021 as dose 3 (booster), single (Lot number: FF2588), in left arm and on 19May2022 as dose 4 (booster), single (Lot number: FJU989) at the age of 77 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "known allergies Sulfa" (unspecified if ongoing); "gerd" (unspecified if ongoing); "General allergies" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Cipro, reaction(s): "known allergies cipro". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient took Anti-viral drug Paxlovid from 31May2022 to 07Jun2022 for COVID 19 treatment.  No follow-up attempts are possible. No further information is expected.
Soreness under both arms for 1 week after injection. Felt sore and tender to touch around lymph nodes under arm.
Extreme muscle spasms and pain at injection site 30 minites after shot was administered. Couldn't move vaccinated arm the next morning.
Patient received both Flu and ZOSTAVAX vaccines on 9/26/12. Few hours later she developed rash and like chicken pox at the chest and upper torso. Feel pain and ache at the T2-L2. She was administered BENADRYL and shot for pain. Later discharged. Still feel sick and had rash one day later.
Runny nose, sneezing. Headaches, body aches, stomach cramps. Woke up with large bumps on back of neck, extreme body aches, hot flashes, dry mouth. Stopped by hospital at 1 pm, seen nurse. She gained bumps. Said swelling in back of neck was unusual. If not better by Wednesday, see doctor. I ask if I was contagious if I could get my HBV shot that was scheduled that day. She said if I wasn't running fever I wasn't contagious and that it would be ok to get shot.  Went to work. Received HBV shot at 1:30 pm. Starting at around 4 pm: Dizziness, nausea, hot flashes, blurred vision, fever. Told nurse on duty. Wasn't better by 5 pm. Requested to go home. Went home. 6:30 pm at home: Fever all night. 5-4-04 no fever, called work, stated problems, went in. Dry mouth hot flashes. 5-5-05 woke up with rash. Called in work. Seen doctor at 3 pm. Itching also, dry mouth.
Shingles - very bad. Shot did not help. Rash is going away after 4 weeks but pain is worse. Cannot function.
Had a fever, chills, headache, fatigue until 36 hours past shot. These did not start until 12 hours post shot.  I have since had a late period with no pregnancy.
One hour after administration, body aches, fever, eye irritation, felt anxious, 5 hours later fatigue; presents to er 2 days later due to eye irritation
Conjunctivitis bilateral, rash chest and back, swollen glands back of neck, started 10 days after injection.
Experienced an "electrical fire or electric jolt" in the left shoulder to upper left quadrant of his chest; Feeling lasted about 6 hours, which was how long the achiness feeling lasted.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old male patient received BNT162b2 (COMIRNATY), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: ELECTRIC SHOCK SENSATION (non-serious), outcome "recovered", described as "Experienced an "electrical fire or electric jolt" in the left shoulder to upper left quadrant of his chest"; PAIN (non-serious), outcome "recovered", described as "Feeling lasted about 6 hours, which was how long the achiness feeling lasted.".  Additional information: This feeling lasted about 6 hours. Event took place after use of product.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201307960 same reporter/AE/SD, different patient;
This case was reported by a nurse via sales rep and described the occurrence of fatigue in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fatigue and myalgia. On an unknown date, the outcome of the fatigue and myalgia were unknown. It was unknown if the reporter considered the fatigue and myalgia to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had fatigue and myalgia and missed a days work. The reporter agreed for follow up. This case has been linked with case US2018GSK153230, reported by the same reporter.
- Localized erythema and swelling, upper body pruritus and mild erythemic rash, throat itchiness, mild shortness of breath. - Employee self treated with Benadryl and Zyrtec: Improving symptoms